Trellis Bioscience
Redwood City, US · Delaware corporation · 3 known investors
Founders & leadership
LK
Larry KauvarChief Science Officer
SR
Stefan RyserPresident and Chief Executive Officer
GD
Geoff DillonChief Business Officer
EW
Elisabeth WhitneyChief Operating Officer
NM
Nora MendeChief Financial Officer
Investors · 3
Funding
SEC filings, press & company announcements$15.1M disclosed across 2 rounds · 2026
- $9MSeries CJul 2026Source ↗
▶$6.1MraisedMay 2026 · 16 investors · BiotechnologyRule 506(b)
▶$6.1MraisedMay 2026 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stefan RyserExecutive Officer
- Geoff DillonExecutive Officer
- Larry KauvarExecutive Officer
- Elisabeth WhitneyExecutive Officer
- Nora MendeExecutive Officer
- Amount sold
- $6.1M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Trellis Bioscience Raises $9M in Series C Fundingfinsmes.com · Jul 2026
Trellis Bioscience Raises $9 Million to Advance Phase 2 Trial of Biofilm-Targeting Therapy for Prosthetic Joint Infections | citybizcitybiz.co · Jul 2026Frequently asked questions
- Who founded Trellis Bioscience?
- Trellis Bioscience was founded by Larry Kauvar.
- Who are Trellis Bioscience's investors?
- Trellis Bioscience's investors include AMR Action Fund, Easton Capital, New Science Ventures.
- How much funding has Trellis Bioscience raised?
- Trellis Bioscience has disclosed $15.1M raised across 2 rounds.
- Where is Trellis Bioscience headquartered?
- Trellis Bioscience is headquartered in Redwood City, US.